BIO-key shareholders advance governance, extend warrant vote timeline
TipRanks (Tue, 6-Oct 5:20 PM ET)
BIO-key taps Al Majlis Group to take biometric IAM into UAE and Saudi Arabia
Market Chameleon (Tue, 29-Sep 5:41 AM ET)
BIO-key Partners with Al Majlis Group to Expand Identity Security Across Arabian Gulf
Globe Newswire (Tue, 29-Sep 3:30 AM ET)
Globe Newswire (Wed, 23-Sep 7:59 AM ET)
Globe Newswire (Tue, 1-Sep 7:59 AM ET)
Globe Newswire (Thu, 13-Aug 5:00 PM ET)
BIO-key International Enters into $2.5 Million Warrant Inducement Transaction
Globe Newswire (Tue, 11-Aug 8:30 AM ET)
Portuguese National Security Agency Selects BIO-key and Visualforma to Strengthen Identity Security
Globe Newswire (Mon, 10-Aug 3:59 AM ET)
Globe Newswire (Fri, 7-Aug 7:59 AM ET)
BIO-key and Maktabi Tech Partner to Advance Identity Security Across Saudi Arabia's Education Sector
Globe Newswire (Thu, 6-Aug 6:59 AM ET)
BIO-key International Inc is a identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and high-quality, low-cost accessory fingerprint scanner and FIDO-compliant hardware to provide a full and complete solution for identity-innovating customers. The company operates as one operating segment. Its solutions are Passwordless Authentication, Secure Roving Employees, Education, Financial Services, Government, Healthcare, Manufacturing, etc.
Bio-Key International trades on the NASDAQ stock market under the symbol BKYI.
As of October 9, 2026, BKYI stock price declined to $1.73 with 30,596 million shares trading.
BKYI has a beta of -2.50, meaning it tends to be less sensitive to market movements. BKYI has a correlation of 0.08 to the broad based SPY ETF.
BKYI has a market cap of $2.48 million. This is considered a Sub-Micro Cap stock.
Last quarter Bio-Key International reported $2 million in Revenue and -$.56 earnings per share. This beat revenue expectation by $120,000 and exceeded earnings estimates by $.26.
BKYI support price is $1.56 and resistance is $1.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BKYI shares will trade within this expected range on the day.
